Biomarkers for a less invasive strategy to predict children with eosinophilic esophagitis
Allergy · 2024
DOI: 10.1111/all.16275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Helena Thulin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science and Education, South Hospital, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Biomarkers. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Astma- och Allergiförbundet, Mjölkdroppen, Stiftelsen Lars Hiertas Minne.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Noninvasive biomarkers for diagnosing and monitoring eosinophilic esophagitis (EoE) are currently lacking. This study evaluates 20 biomarkers in serum and saliva, aiming to assess their diagnostic potential in pediatric EoE patients and healthy individuals.
Methods
Blood and saliva from children undergoing upper endoscopy were analyzed for biomarkers, including absolute eosinophil count (AEC), eosinophil‐derived neurotoxin (EDN), total and specific IgG 4 ‐antibodies (sIgG 4 ), specific IgE‐antibodies (sIgE) and 15‐hydroxyeicosatetraenoic acid (15(S)‐HETE). Some patients participated twice, forming a longitudinal cohort. The ability to use the biomarkers to predict the EoE diagnosis was evaluated.
Results
Analysis from 105 children divided into active EoE, remission, and healthy, revealed elevated levels of serum biomarkers (AEC, EDN, 15(S)‐HETE, sIgG 4 , and sIgE) in active EoE compared to healthy individuals. A combination of biomarkers (AEC, EDN, sIgE to egg white and wheat) and symptoms showed an AUC of 0.92 in distinguishing between the three groups. We further showed that optimal cutoff values for these biomarkers could discriminate between active EoE and healthy with a sensitivity of 88% and a specificity of 100% in distinguishing EoE (active and in remission) from healthy. Longitudinally, levels of EDN, sIgG 4 to Bos d 4, Bos d 5, Bos d 8, gliadin, and birch, and sIgE to milk decreased in patients progressing from active EoE to remission ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Science and Education, South Hospital, Karolinska Institutet, Stockholm, Sweden.
- Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
- Clinical Epidemiology Division, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
- Department of Medical Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
- Sachs Children and Youth Hospital, South Hospital, Stockholm, Sweden.
- Unit of Integrative Metabolomics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Helena Thulin, Ladan Mansouri, Maria Altman, Simon Kebede Merid, Joachim Lundahl, Caroline Nilsson, Jesper Säfholm
Förderung
- Astma- och Allergiförbundet
- Mjölkdroppen
- Stiftelsen Lars Hiertas Minne
- Cayman Biomedical Research Institute
- Åke Wibergs foundation
- Magnus Bergvalls foundation
- Hjärt-Lungfonden
Zitieren
APA
Thulin, H., Mansouri, L., Altman, M., Merid, S. K., Lundahl, J., Nilsson, C., & Säfholm, J. (2024). Biomarkers for a less invasive strategy to predict children with eosinophilic esophagitis. Allergy. https://doi.org/10.1111/all.16275
Vancouver
Thulin H, Mansouri L, Altman M, Merid SK, Lundahl J, Nilsson C, et al. Biomarkers for a less invasive strategy to predict children with eosinophilic esophagitis. Allergy. 2024. doi:10.1111/all.16275
BibTeX
@article{Thulin2024,
author = {Thulin, Helena and Mansouri, Ladan and Altman, Maria and Merid, Simon Kebede and Lundahl, Joachim and Nilsson, Caroline and Säfholm, Jesper},
title = {Biomarkers for a less invasive strategy to predict children with eosinophilic esophagitis},
journal = {Allergy},
year = {2024},
doi = {10.1111/all.16275}
}
EUVIMED